Anaplastic large cell lymphoma (ALCL), a distinct subtype of T-cell non-Hodgkin lymphoma, has been the subject of vigorous research efforts over recent years. Investigations have focused on improving ...

National population-based analysis of demographics and outcomes of patients diagnosed with extranodal NK/T-cell nasal type lymphoma in the US: Does ethnicity play a role? This is an ASCO Meeting ...

Lymphomas belong to the group of malignant diseases of the immune system and mainly affect the organs of the lymphatic system. Anaplastic large cell lymphoma (ALCL) belongs to the subgroup of ...

A collaboration between scientists from St. Jude Children's Research Hospital and Dana-Farber Cancer Institute uncovered four proteins that govern the identity of anaplastic large cell lymphoma (ALCL) ...

Frontline brentuximab vedotin (BV) and CHP in patients (pts) with peripheral T-cell lymphoma (PTCL) with 10% CD30 expression: Primary analysis results from the phase 2 SGN35-032 study. Safety and ...

Brentuximab vedotin is currently funded only for people whose lymphoma has returned or has not responded to earlier treatment. Using brentuximab vedotin earlier is expected to support better outcomes ...

Columbia University investigators report an increased risk of breast lymphomas after postmastectomy implant-based reconstruction, including anaplastic large-cell lymphoma and several B-cell and T-cell ...